article thumbnail

Scandinavia: insight into opportunities for drug discovery

Drug Discovery World

Though not without its challenges, the life sciences industry in Scandinavia is well represented and acts as a serious contender for R&D output. More so, the Karolinska Institute is ranked at number seven in the world for the subjects of life sciences and medicine.

article thumbnail

Combining the Powers of Single Cell Sequencing and AI in Understanding Disease Biology and Drug Development

XTalks

Visium Spatial Gene Expression Solution. To address challenges associated with loss of spatial context, 10x Genomics has developed the Visium Spatial Gene Expression solution, which enables answering biological questions in the context of tissue using an unbiased gene expression approach.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Elixirgen Therapeutics’ Innovative Approach to mRNA Therapeutics

XTalks

Founded in Baltimore, Maryland, a vibrant science hub, Elixirgen Therapeutics emerged from a vision to harness the untapped potential of mRNA technology. In a field quickly gaining attention for its role in vaccine development and personalized medicine, Elixirgen Therapeutics stands out through its pursuit of innovation and safety.

Protein 52
article thumbnail

Synthetic biology: Innovating in drug discovery

Drug Discovery World

At MaxCyte, we are passionate about driving the discovery, development and manufacturing of next-generation, cell-based medicines to tackle complex diseases and cancer. Evonetix hopes the platform can change the way DNA is prepared and delivered to users within synthetic biology and helps accelerate research across life sciences.

Drugs 52
article thumbnail

Artificial intelligence could be new blueprint for precision drug discovery

The Pharma Data

online issue of Nature Communications, researchers at University of California San Diego School of Medicine describe a new approach that uses machine learning to hunt for disease targets and then predicts whether a drug is likely to receive FDA approval. “Academic labs and pharmaceutical and? the success rates in drug discovery?are

Drugs 52
article thumbnail

Otto Bayer Award goes to Prof. Ruth Ley PhD

The Pharma Data

Her cryo-electron microscopy studies include analysis of nuclear peripheries and the machinery of gene expression in bacteria. In the Medicine category Dr. Nicolai Franzmeier (LMU Munich) was honored for developing new imaging techniques to investigate Alzheimer’s disease.

article thumbnail

What the Glycome Can Tell Us About Persistent HIV Infection

XTalks

The importance of identifying and combining signatures across multiple realms, from gene expression to the proteome to the glycome, is important in the effective identification, classification and therapeutic targeting of disease in a more specified and personalized manner, and in contributing to our overall understanding of biological processes.

RNA 52